US Patent Issued to Merck Sharp & Dohme on Aug. 4 for "Thermostable lipid nanoparticle and methods of use thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,308, issued on Aug. 4, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Thermostable lipid nanoparticle and methods of use thereof" was invented by Andrew Bett (Lansdale, Pa.), Izzat T. Raheem (Doylestown, Pa.) and Jason W. Skudlarek (Abdubon, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides, among other things, a lipid nanoparticle adjuvant composition. The present disclosure provides pharmaceutical compositions that include a stable lipid nanoparticle adjuvant and human papillomavirus (HPV) virus-like particles (VLPs) of at least one type of human papillomavirus (HPV) selected from the group consisting of H...